EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study

Naoki Yoshioka iD, Takahiro Tokuda iD, Akiko Tanaka, Shunsuke Kojima, Kohei Yamaguchi, Takashi Yanagiuchi iD, Kenji Ogata iD, Tatsuro Takei, Yasuhiro Morita, Tatsuya Nakama iD, Itsuro Morishima, LEADers PAD investigators

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31485 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Naoki Yoshioka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan. Hauptthemen laut MEDLINE: Popliteal Artery, Femoral Artery, Peripheral Arterial Disease, Coated Materials, Biocompatible. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies have shown comparable outcomes between first‐generation high‐dose drug‐coated balloon (HD‐DCB) and second‐generation low‐dose drug‐coated balloon (LD‐DCB) for femoropopliteal artery disease. However, data about the clinical performances of these DCBs for longer lesions in real‐world clinical settings are limited.

Methods

In this multicenter, retrospective study, the clinical performances of the HD‐DCB (IN.PACT, Medtronic, MN, USA) and the LD‐DCB (Ranger, Boston, MA, USA) were assessed in cases of femoropopliteal artery disease with lesion length ≥ 150 mm. From the database, 288 lesions in 288 patients were assigned to the HD‐DCB group, and 88 lesions in 88 patients were assigned to the LD‐DCB group. Propensity score‐matching analysis was performed to adjust for baseline patient and lesion characteristics. The primary outcome was the 2‐year primary patency rate of the two types of DCBs.

Results

Propensity score matching was used to extract 76 pairs with no significant intergroup differences in baseline patient and lesion characteristics. The average lesion length was 257.5 and 255.7 mm in the HD and LD‐DCB groups, respectively. The 2‐year primary patency rates between the HD and LD‐DCB groups were comparable (68.5% vs. 60.4%; p = 0.33). There were also no significant differences in clinically driven target lesion revascularization, acute limb ischemia, major amputation, or overall survival between the two types of DCBs.

Conclusion

The clinical outcomes between the HD and LD‐DCBs did not significantly differ in real‐world populations with severely complex lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Popliteal ArteryFemoral ArteryPeripheral Arterial DiseaseCoated Materials, BiocompatibleVascular Access DevicesCardiovascular AgentsAngioplasty, BalloonPaclitaxelHumansRetrospective StudiesMaleFemaleVascular PatencyAgedTreatment OutcomeTime FactorsMiddle AgedEquipment DesignRisk FactorsLimb SalvageDatabases, FactualAmputation, SurgicalAged, 80 and over

Stichwörter der Autor:innen

drug‐coated balloonsendovascular therapylong lesionlower extremity peripheral artery diseasepropensity score matching

Substanzen

Coated Materials, BiocompatibleCardiovascular AgentsPaclitaxel

Autor:innen und Institutionen

  • Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
  • Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
  • Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
  • Department of Cardiology, Saiseikai Yokohama City Eastern Hospital, Yokohama, Japan.
  • Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan.

ORCID-Profile: Naoki Yoshioka, Takahiro Tokuda, Takashi Yanagiuchi, Kenji Ogata, Tatsuya Nakama

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Yoshioka, N., Tokuda, T., Tanaka, A., Kojima, S., Yamaguchi, K., Yanagiuchi, T., Ogata, K., Takei, T., Morita, Y., Nakama, T., Morishima, I., & LEADers PAD investigators (2025). Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31485

Vancouver

Yoshioka N, Tokuda T, Tanaka A, Kojima S, Yamaguchi K, Yanagiuchi T, et al. Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31485

BibTeX
@article{Yoshioka2025,
  author = {Yoshioka, Naoki and Tokuda, Takahiro and Tanaka, Akiko and Kojima, Shunsuke and Yamaguchi, Kohei and Yanagiuchi, Takashi and Ogata, Kenji and Takei, Tatsuro and Morita, Yasuhiro and Nakama, Tatsuya and Morishima, Itsuro and LEADers PAD investigators, LEADers PAD investigators},
  title = {Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31485}
}
Kostenlos starten →